IMCD/€IMCD
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About IMCD
IMCD N.V. specializes in the distribution and formulation of chemicals and ingredients. Founded in 1995 and headquartered in Rotterdam, the Netherlands, the company operates in numerous countries across the world, serving a wide range of industries. IMCD provides value-added services such as technical support, formulation, marketing, and logistics, leveraging its extensive network to deliver tailored solutions that enhance product performance and facilitate innovation.
Ticker
€IMCD
Sector
Primary listing
AEX
Industry
Trading Companies & Distributors
Headquarters
Employees
5,126
ISIN
NL0010801007
Website
IMCD Metrics
BasicAdvanced
€6.6B
23.17
€4.86
1.05
€2.15
1.91%
Price and volume
Market cap
€6.6B
Beta
1.05
52-week high
€156.30
52-week low
€109.35
Average daily volume
116K
Dividend rate
€2.15
Financial strength
Current ratio
1.979
Quick ratio
1.268
Long term debt to equity
63.088
Total debt to equity
81.575
Dividend payout ratio (TTM)
45.88%
Interest coverage (TTM)
6.03%
Profitability
EBITDA (TTM)
539.819
Gross margin (TTM)
25.74%
Net profit margin (TTM)
5.86%
Operating margin (TTM)
9.17%
Effective tax rate (TTM)
26.78%
Revenue per employee (TTM)
€930,000
Management effectiveness
Return on assets (TTM)
6.02%
Return on equity (TTM)
14.12%
Valuation
Price to earnings (TTM)
23.169
Price to revenue (TTM)
1.357
Price to book
2.99
Price to tangible book (TTM)
-16.76
Price to free cash flow (TTM)
25.488
Free cash flow yield (TTM)
3.92%
Free cash flow per share (TTM)
441.78%
Dividend yield (TTM)
1.91%
Forward dividend yield
1.91%
Growth
Revenue change (TTM)
6.36%
Earnings per share change (TTM)
-5.26%
3-year revenue growth (CAGR)
11.19%
10-year revenue growth (CAGR)
13.27%
3-year earnings per share growth (CAGR)
10.22%
10-year earnings per share growth (CAGR)
19.92%
3-year dividend per share growth (CAGR)
9.89%
10-year dividend per share growth (CAGR)
26.81%
What the Analysts think about IMCD
Analyst ratings (Buy, Hold, Sell) for IMCD stock.
Bulls say / Bears say
IMCD's successful capital raise of EUR 300 million in November 2024 enhances its financial flexibility and strengthens its balance sheet, positioning the company for future growth initiatives. (globenewswire.com)
Goldman Sachs maintains a 'Buy' rating on IMCD, citing accelerated organic growth and a promising return to normalized growth in 2025. (investing.com)
IMCD's strategic acquisitions, such as the purchase of Trichem Healthcare in June 2025, expand its pharmaceutical offerings in India, potentially driving revenue growth. (marketscreener.com)
The unexpected resignation of CEO Valerie Diele-Braun in April 2025 led to a significant share price drop, raising concerns about leadership stability. (investing.com)
IMCD's net income declined by 4.8% in FY 2024 compared to the previous year, indicating potential profitability challenges. (marketscreener.com)
The profit margin decreased to 5.9% in FY 2024 from 6.5% in FY 2023, driven by higher expenses, which may impact future earnings. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.
IMCD Financial Performance
Revenues and expenses
IMCD Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for IMCD stock?
IMCD (IMCD) has a market cap of €6.6B as of July 12, 2025.
What is the P/E ratio for IMCD stock?
The price to earnings (P/E) ratio for IMCD (IMCD) stock is 23.17 as of July 12, 2025.
Does IMCD stock pay dividends?
Yes, the IMCD (IMCD) stock pays dividends to shareholders. As of July 12, 2025, the dividend rate is €2.15 and the yield is 1.91%. IMCD has a payout ratio of 45.88% on a trailing twelve-month basis.
When is the next IMCD dividend payment date?
The next IMCD (IMCD) dividend payment date is unconfirmed.
What is the beta indicator for IMCD?
IMCD (IMCD) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.